Non-Current Assets

Short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84)

Thermo Fisher Scientific Short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84) decreased by 99.2% to $2.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 99.9%, from $1.81B to $2.00M. Over 2 years (FY 2023 to FY 2025), Short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84) shows an upward trend with a 818.3% CAGR.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryLiquidity
SignalContext dependent
VolatilityModerate
First reportedQ4 2023
Last reportedQ1 2026May 1, 2026

How to read this metric

An increase suggests a conservative cash management strategy or accumulation of capital for future strategic investments, while a decrease may indicate cash deployment for acquisitions or capital expenditures.

Detailed definition

This represents liquid financial instruments held by the company that are intended to be held for more than one year or...

Peer comparison

Commonly reported by technology firms with significant cash balances; peers often hold similar portfolios of marketable securities.

Metric ID: non_current_assets_short_term_investments

Historical Data

10 periods
 Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$3.00M$1.75B$1.75B$2.00B$1.56B$1.81B$1.81B$1.56B$253.00M$2.00M
QoQ Change>999%-0.1%+14.3%-21.9%+16.1%+0.1%-13.8%-83.8%-99.2%
YoY Change>999%+3.5%+3.7%-21.8%-83.8%-99.9%
Range$2.00M$2.00B
CAGR-16.5%
Avg YoY Growth>999%
Median YoY Growth-9.1%
Current Streak3 quarters decline

Short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84) at Other Companies

Frequently Asked Questions

What is Thermo Fisher Scientific's short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84)?
Thermo Fisher Scientific (TMO) reported short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84) of $2.00M in Q1 2026.
How has Thermo Fisher Scientific's short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84) changed year-over-year?
Thermo Fisher Scientific's short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84) decreased by 99.9% year-over-year, from $1.81B to $2.00M.
What is the long-term trend for Thermo Fisher Scientific's short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84)?
Over 2 years (2023 to 2025), Thermo Fisher Scientific's short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84) has grown at a 818.3% compound annual growth rate (CAGR), from $3.00M to $253.00M.
What does short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84) mean?
Financial investments held by the company that are not immediately available for daily operations.